Post–Acute Care Use and Hospital Readmission after Sepsis

Tiffanie K. Jones(University of Pennsylvania), Mark E. Mikkelsen(Pulmonary and Allergy Associates), Asaf Hanish(University of Pennsylvania Health System), Craig A. Umscheid(University of Pennsylvania Health System), Scott D. Halpern(University of Pennsylvania), Dylan S. Small(University of Pennsylvania), David F. Gaieski(Thomas Jefferson University Hospital), Meeta Prasad Kerlin(Pulmonary and Allergy Associates), Barry D. Fuchs(University of Pennsylvania), Charles A. Baillie(Center for Clinical Research (United States))
Annals of the American Thoracic Society
March 9, 2015
10.1513/annalsats.201411-504oc
Cited by 137

Related Papers

Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial
|The Lancet|2008|2k
Comprehensive mapping of immune perturbations associated with severe COVID-19
|Science Immunology|2020|806
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
|Nature Medicine|2021|521
Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis
|JAMA|2021|285
Complement factor H or a related protein is a marker for transitional cell cancer of the bladder.
|PubMed|1998|128